Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

The NIH funding will help address a "traditional barrier" to health care, says Elizabeth Evans, professor of community health ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite growing availability of a highly effective HIV ...

When diagnosed with HIV, the timing of treatment initiation can significantly impact long-term health outcomes and quality of life. Medical experts increasingly advocate for immediate treatment ...

By Aneri Pattani for KFF Health News. Broadcast version by Kathryn Carley for Maine News Service reporting for the KFF Health ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...

Shionogi now plans to accelerate its expansion in Europe and the U.S., while pursuing full-scale growth of its new drug ...

The Health departmental officials said that “a new plan will be shared" for when the funding ends in March 2026.